Financhill
Sell
44

CON Quote, Financials, Valuation and Earnings

Last price:
$19.69
Seasonality move :
13.68%
Day range:
$19.66 - $20.05
52-week range:
$18.55 - $24.17
Dividend yield:
1.27%
P/E ratio:
16.53x
P/S ratio:
1.20x
P/B ratio:
6.54x
Volume:
484.7K
Avg. volume:
821.3K
1-year change:
-0.51%
Market cap:
$2.5B
Revenue:
$1.9B
EPS (TTM):
$1.19

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CON
Concentra Group Holdings Parent, Inc.
$532M $0.23 14.4% 35.1% $28.43
EHC
Encompass Health Corp.
$1.5B $1.30 9.64% 10.17% $140.33
NAKA
Kindly MD, Inc.
$394.1K -$0.01 -34.74% -94.11% $1.25
SRXH
SRx Health Solutions, Inc.
-- -- -- -- --
TOI
The Oncology Institute, Inc.
$139.8M -$0.10 39.41% -52.63% $6.50
USPH
U.S. Physical Therapy, Inc.
$200.1M $0.67 10.89% 28.38% $105.33
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CON
Concentra Group Holdings Parent, Inc.
$19.68 $28.43 $2.5B 16.53x $0.06 1.27% 1.20x
EHC
Encompass Health Corp.
$106.14 $140.33 $10.7B 20.06x $0.19 0.66% 1.87x
NAKA
Kindly MD, Inc.
$0.35 $1.25 $2.7M -- $0.00 0% 9.84x
SRXH
SRx Health Solutions, Inc.
$0.23 -- $6.3M 0.14x $0.00 0% 0.04x
TOI
The Oncology Institute, Inc.
$3.56 $6.50 $350.2M -- $0.00 0% 0.66x
USPH
U.S. Physical Therapy, Inc.
$78.09 $105.33 $1.2B 32.85x $0.45 2.31% 1.56x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CON
Concentra Group Holdings Parent, Inc.
84.73% 0.165 78.98% 1.05x
EHC
Encompass Health Corp.
52.86% -0.034 19.56% 0.97x
NAKA
Kindly MD, Inc.
29.88% 45.104 2500.93% 0.11x
SRXH
SRx Health Solutions, Inc.
13.36% -3.730 -- 1.30x
TOI
The Oncology Institute, Inc.
113.45% -0.225 30.41% 1.33x
USPH
U.S. Physical Therapy, Inc.
37.98% 1.471 19.64% 0.90x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CON
Concentra Group Holdings Parent, Inc.
$147.4M $96.7M 6.61% 46.67% 16.88% $39.4M
EHC
Encompass Health Corp.
$299.7M $243.6M 12.69% 24.34% 16.49% $83.7M
NAKA
Kindly MD, Inc.
-$6.1M -$10.4M -64.63% -91.57% -2680.45% -$692.1M
SRXH
SRx Health Solutions, Inc.
$2.4M -$1.1M -- -- -15.2% $377K
TOI
The Oncology Institute, Inc.
$17.2M -$8.1M -48.97% -9486.64% -5.9% -$13.2M
USPH
U.S. Physical Therapy, Inc.
$33.1M $19.5M 6.17% 8.6% 9.89% $16.1M

Concentra Group Holdings Parent, Inc. vs. Competitors

  • Which has Higher Returns CON or EHC?

    Encompass Health Corp. has a net margin of 8.7% compared to Concentra Group Holdings Parent, Inc.'s net margin of 11.82%. Concentra Group Holdings Parent, Inc.'s return on equity of 46.67% beat Encompass Health Corp.'s return on equity of 24.34%.

    Company Gross Margin Earnings Per Share Invested Capital
    CON
    Concentra Group Holdings Parent, Inc.
    25.73% $0.37 $2.5B
    EHC
    Encompass Health Corp.
    20.28% $1.24 $5.8B
  • What do Analysts Say About CON or EHC?

    Concentra Group Holdings Parent, Inc. has a consensus price target of $28.43, signalling upside risk potential of 44.45%. On the other hand Encompass Health Corp. has an analysts' consensus of $140.33 which suggests that it could grow by 32.22%. Given that Concentra Group Holdings Parent, Inc. has higher upside potential than Encompass Health Corp., analysts believe Concentra Group Holdings Parent, Inc. is more attractive than Encompass Health Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    CON
    Concentra Group Holdings Parent, Inc.
    5 0 0
    EHC
    Encompass Health Corp.
    11 0 0
  • Is CON or EHC More Risky?

    Concentra Group Holdings Parent, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Encompass Health Corp. has a beta of 0.756, suggesting its less volatile than the S&P 500 by 24.396%.

  • Which is a Better Dividend Stock CON or EHC?

    Concentra Group Holdings Parent, Inc. has a quarterly dividend of $0.06 per share corresponding to a yield of 1.27%. Encompass Health Corp. offers a yield of 0.66% to investors and pays a quarterly dividend of $0.19 per share. Concentra Group Holdings Parent, Inc. pays 4.81% of its earnings as a dividend. Encompass Health Corp. pays out 14.35% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CON or EHC?

    Concentra Group Holdings Parent, Inc. quarterly revenues are $572.8M, which are smaller than Encompass Health Corp. quarterly revenues of $1.5B. Concentra Group Holdings Parent, Inc.'s net income of $49.8M is lower than Encompass Health Corp.'s net income of $174.7M. Notably, Concentra Group Holdings Parent, Inc.'s price-to-earnings ratio is 16.53x while Encompass Health Corp.'s PE ratio is 20.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent, Inc. is 1.20x versus 1.87x for Encompass Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CON
    Concentra Group Holdings Parent, Inc.
    1.20x 16.53x $572.8M $49.8M
    EHC
    Encompass Health Corp.
    1.87x 20.06x $1.5B $174.7M
  • Which has Higher Returns CON or NAKA?

    Kindly MD, Inc. has a net margin of 8.7% compared to Concentra Group Holdings Parent, Inc.'s net margin of -22162.75%. Concentra Group Holdings Parent, Inc.'s return on equity of 46.67% beat Kindly MD, Inc.'s return on equity of -91.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    CON
    Concentra Group Holdings Parent, Inc.
    25.73% $0.37 $2.5B
    NAKA
    Kindly MD, Inc.
    -1565.61% -$0.42 $681.1M
  • What do Analysts Say About CON or NAKA?

    Concentra Group Holdings Parent, Inc. has a consensus price target of $28.43, signalling upside risk potential of 44.45%. On the other hand Kindly MD, Inc. has an analysts' consensus of $1.25 which suggests that it could grow by 256.02%. Given that Kindly MD, Inc. has higher upside potential than Concentra Group Holdings Parent, Inc., analysts believe Kindly MD, Inc. is more attractive than Concentra Group Holdings Parent, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CON
    Concentra Group Holdings Parent, Inc.
    5 0 0
    NAKA
    Kindly MD, Inc.
    1 0 0
  • Is CON or NAKA More Risky?

    Concentra Group Holdings Parent, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Kindly MD, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CON or NAKA?

    Concentra Group Holdings Parent, Inc. has a quarterly dividend of $0.06 per share corresponding to a yield of 1.27%. Kindly MD, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concentra Group Holdings Parent, Inc. pays 4.81% of its earnings as a dividend. Kindly MD, Inc. pays out -- of its earnings as a dividend. Concentra Group Holdings Parent, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CON or NAKA?

    Concentra Group Holdings Parent, Inc. quarterly revenues are $572.8M, which are larger than Kindly MD, Inc. quarterly revenues of $388.2K. Concentra Group Holdings Parent, Inc.'s net income of $49.8M is higher than Kindly MD, Inc.'s net income of -$86M. Notably, Concentra Group Holdings Parent, Inc.'s price-to-earnings ratio is 16.53x while Kindly MD, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent, Inc. is 1.20x versus 9.84x for Kindly MD, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CON
    Concentra Group Holdings Parent, Inc.
    1.20x 16.53x $572.8M $49.8M
    NAKA
    Kindly MD, Inc.
    9.84x -- $388.2K -$86M
  • Which has Higher Returns CON or SRXH?

    SRx Health Solutions, Inc. has a net margin of 8.7% compared to Concentra Group Holdings Parent, Inc.'s net margin of -13.47%. Concentra Group Holdings Parent, Inc.'s return on equity of 46.67% beat SRx Health Solutions, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CON
    Concentra Group Holdings Parent, Inc.
    25.73% $0.37 $2.5B
    SRXH
    SRx Health Solutions, Inc.
    33.29% -$0.07 $9.2M
  • What do Analysts Say About CON or SRXH?

    Concentra Group Holdings Parent, Inc. has a consensus price target of $28.43, signalling upside risk potential of 44.45%. On the other hand SRx Health Solutions, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Concentra Group Holdings Parent, Inc. has higher upside potential than SRx Health Solutions, Inc., analysts believe Concentra Group Holdings Parent, Inc. is more attractive than SRx Health Solutions, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CON
    Concentra Group Holdings Parent, Inc.
    5 0 0
    SRXH
    SRx Health Solutions, Inc.
    0 0 0
  • Is CON or SRXH More Risky?

    Concentra Group Holdings Parent, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SRx Health Solutions, Inc. has a beta of 0.882, suggesting its less volatile than the S&P 500 by 11.819%.

  • Which is a Better Dividend Stock CON or SRXH?

    Concentra Group Holdings Parent, Inc. has a quarterly dividend of $0.06 per share corresponding to a yield of 1.27%. SRx Health Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concentra Group Holdings Parent, Inc. pays 4.81% of its earnings as a dividend. SRx Health Solutions, Inc. pays out -- of its earnings as a dividend. Concentra Group Holdings Parent, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CON or SRXH?

    Concentra Group Holdings Parent, Inc. quarterly revenues are $572.8M, which are larger than SRx Health Solutions, Inc. quarterly revenues of $7.2M. Concentra Group Holdings Parent, Inc.'s net income of $49.8M is higher than SRx Health Solutions, Inc.'s net income of -$964K. Notably, Concentra Group Holdings Parent, Inc.'s price-to-earnings ratio is 16.53x while SRx Health Solutions, Inc.'s PE ratio is 0.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent, Inc. is 1.20x versus 0.04x for SRx Health Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CON
    Concentra Group Holdings Parent, Inc.
    1.20x 16.53x $572.8M $49.8M
    SRXH
    SRx Health Solutions, Inc.
    0.04x 0.14x $7.2M -$964K
  • Which has Higher Returns CON or TOI?

    The Oncology Institute, Inc. has a net margin of 8.7% compared to Concentra Group Holdings Parent, Inc.'s net margin of -10.08%. Concentra Group Holdings Parent, Inc.'s return on equity of 46.67% beat The Oncology Institute, Inc.'s return on equity of -9486.64%.

    Company Gross Margin Earnings Per Share Invested Capital
    CON
    Concentra Group Holdings Parent, Inc.
    25.73% $0.37 $2.5B
    TOI
    The Oncology Institute, Inc.
    12.59% -$0.14 $91.3M
  • What do Analysts Say About CON or TOI?

    Concentra Group Holdings Parent, Inc. has a consensus price target of $28.43, signalling upside risk potential of 44.45%. On the other hand The Oncology Institute, Inc. has an analysts' consensus of $6.50 which suggests that it could grow by 82.58%. Given that The Oncology Institute, Inc. has higher upside potential than Concentra Group Holdings Parent, Inc., analysts believe The Oncology Institute, Inc. is more attractive than Concentra Group Holdings Parent, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CON
    Concentra Group Holdings Parent, Inc.
    5 0 0
    TOI
    The Oncology Institute, Inc.
    3 0 0
  • Is CON or TOI More Risky?

    Concentra Group Holdings Parent, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Oncology Institute, Inc. has a beta of 0.151, suggesting its less volatile than the S&P 500 by 84.902%.

  • Which is a Better Dividend Stock CON or TOI?

    Concentra Group Holdings Parent, Inc. has a quarterly dividend of $0.06 per share corresponding to a yield of 1.27%. The Oncology Institute, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concentra Group Holdings Parent, Inc. pays 4.81% of its earnings as a dividend. The Oncology Institute, Inc. pays out -- of its earnings as a dividend. Concentra Group Holdings Parent, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CON or TOI?

    Concentra Group Holdings Parent, Inc. quarterly revenues are $572.8M, which are larger than The Oncology Institute, Inc. quarterly revenues of $136.6M. Concentra Group Holdings Parent, Inc.'s net income of $49.8M is higher than The Oncology Institute, Inc.'s net income of -$13.8M. Notably, Concentra Group Holdings Parent, Inc.'s price-to-earnings ratio is 16.53x while The Oncology Institute, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent, Inc. is 1.20x versus 0.66x for The Oncology Institute, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CON
    Concentra Group Holdings Parent, Inc.
    1.20x 16.53x $572.8M $49.8M
    TOI
    The Oncology Institute, Inc.
    0.66x -- $136.6M -$13.8M
  • Which has Higher Returns CON or USPH?

    U.S. Physical Therapy, Inc. has a net margin of 8.7% compared to Concentra Group Holdings Parent, Inc.'s net margin of 9.98%. Concentra Group Holdings Parent, Inc.'s return on equity of 46.67% beat U.S. Physical Therapy, Inc.'s return on equity of 8.6%.

    Company Gross Margin Earnings Per Share Invested Capital
    CON
    Concentra Group Holdings Parent, Inc.
    25.73% $0.37 $2.5B
    USPH
    U.S. Physical Therapy, Inc.
    16.78% $0.48 $1.1B
  • What do Analysts Say About CON or USPH?

    Concentra Group Holdings Parent, Inc. has a consensus price target of $28.43, signalling upside risk potential of 44.45%. On the other hand U.S. Physical Therapy, Inc. has an analysts' consensus of $105.33 which suggests that it could grow by 34.89%. Given that Concentra Group Holdings Parent, Inc. has higher upside potential than U.S. Physical Therapy, Inc., analysts believe Concentra Group Holdings Parent, Inc. is more attractive than U.S. Physical Therapy, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CON
    Concentra Group Holdings Parent, Inc.
    5 0 0
    USPH
    U.S. Physical Therapy, Inc.
    2 1 0
  • Is CON or USPH More Risky?

    Concentra Group Holdings Parent, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison U.S. Physical Therapy, Inc. has a beta of 1.290, suggesting its more volatile than the S&P 500 by 28.981%.

  • Which is a Better Dividend Stock CON or USPH?

    Concentra Group Holdings Parent, Inc. has a quarterly dividend of $0.06 per share corresponding to a yield of 1.27%. U.S. Physical Therapy, Inc. offers a yield of 2.31% to investors and pays a quarterly dividend of $0.45 per share. Concentra Group Holdings Parent, Inc. pays 4.81% of its earnings as a dividend. U.S. Physical Therapy, Inc. pays out 95.62% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CON or USPH?

    Concentra Group Holdings Parent, Inc. quarterly revenues are $572.8M, which are larger than U.S. Physical Therapy, Inc. quarterly revenues of $197.1M. Concentra Group Holdings Parent, Inc.'s net income of $49.8M is higher than U.S. Physical Therapy, Inc.'s net income of $19.7M. Notably, Concentra Group Holdings Parent, Inc.'s price-to-earnings ratio is 16.53x while U.S. Physical Therapy, Inc.'s PE ratio is 32.85x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent, Inc. is 1.20x versus 1.56x for U.S. Physical Therapy, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CON
    Concentra Group Holdings Parent, Inc.
    1.20x 16.53x $572.8M $49.8M
    USPH
    U.S. Physical Therapy, Inc.
    1.56x 32.85x $197.1M $19.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 1

Corcept Therapeutics, Inc. [CORT] is down 50.44% over the past day.

Buy
75
AXSM alert for Jan 1

Axsome Therapeutics, Inc. [AXSM] is up 22.82% over the past day.

Sell
50
NUTX alert for Jan 1

Nutex Health, Inc. [NUTX] is down 9.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock